SEC61B is essential for platinum drug accumulation, and its knockdown desensitizes cancer cells to oxaliplatin, carboplatin and cisplatin38, while G6PD and PDE3B enhance chemoresistance to oxaliplatin and cisplatin39,54. This evidence concerns the gene SEC61B and cancer.